RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+14.7%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.47B
AUM Growth
+$5.47B
Cap. Flow
+$466M
Cap. Flow %
8.53%
Top 10 Hldgs %
51.96%
Holding
75
New
18
Increased
7
Reduced
14
Closed
5

Top Buys

1
NKTX icon
Nkarta
NKTX
$168M
2
ASND icon
Ascendis Pharma
ASND
$154M
3
MCRB icon
Seres Therapeutics
MCRB
$134M
4
ITOS
iTeos Therapeutics
ITOS
$109M
5
VXRT
Vaxart
VXRT
$71.9M

Top Sells

1
NVAX icon
Novavax
NVAX
$386M
2
TGTX icon
TG Therapeutics
TGTX
$106M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
$84.2M
4
STOK icon
Stoke Therapeutics
STOK
$26.7M
5
AVDL
Avadel Pharmaceuticals
AVDL
$25.3M

Sector Composition

1 Healthcare 93.09%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CNCE
51
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$18.3M 0.33%
1,858,474
– –
STSA
52
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$18.2M 0.33%
4,681,858
– –
MIST icon
53
Milestone Pharmaceuticals
MIST
$151M
$17.7M 0.32%
+2,418,798
New +$17.7M
SNDX icon
54
Syndax Pharmaceuticals
SNDX
$1.39B
$15.1M 0.28%
1,023,067
– –
TNGX icon
55
Tango Therapeutics
TNGX
$745M
$13M 0.24%
+1,250,000
New +$13M
RPTX icon
56
Repare Therapeutics
RPTX
$73.9M
$12.6M 0.23%
409,000
– –
FSDC
57
DELISTED
FS Development Corp. Class A Common Stock
FSDC
$11.2M 0.2%
+1,000,000
New +$11.2M
NAUT icon
58
Nautilus Biotechnolgy
NAUT
$80.7M
$10.8M 0.2%
+1,000,000
New +$10.8M
VSTM icon
59
Verastem
VSTM
$585M
$9.76M 0.18%
8,066,171
-1,063,080
-12% -$1.29M
SLDB icon
60
Solid Biosciences
SLDB
$448M
$9.28M 0.17%
4,571,164
– –
LYRA icon
61
Lyra Therapeutics
LYRA
$11.8M
$9.25M 0.17%
815,849
– –
ARYBU
62
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$7.7M 0.14%
700,000
– –
GRTX
63
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$7.46M 0.14%
825,118
– –
OBIO icon
64
Orchestra BioMed
OBIO
$147M
$6.88M 0.13%
+625,000
New +$6.88M
CLDX icon
65
Celldex Therapeutics
CLDX
$1.57B
$5.24M 0.1%
353,072
-796,928
-69% -$11.8M
ELVN icon
66
Enliven Therapeutics
ELVN
$1.24B
$5.08M 0.09%
249,739
-579,609
-70% -$11.8M
PASG icon
67
Passage Bio
PASG
$22.7M
$4.23M 0.08%
322,630
– –
XFOR icon
68
X4 Pharmaceuticals
XFOR
$70M
$3.79M 0.07%
559,494
– –
EPIX icon
69
ESSA Pharma
EPIX
$11.2M
$3.25M 0.06%
470,428
-378,872
-45% -$2.61M
OVID icon
70
Ovid Therapeutics
OVID
$94.6M
$1.64M 0.03%
285,000
– –
AVDL
71
Avadel Pharmaceuticals
AVDL
$1.42B
– –
-3,126,131
Closed -$25.3M
INSM icon
72
Insmed
INSM
$30.3B
– –
-87,405
Closed -$2.41M
RNAC icon
73
Cartesian Therapeutics
RNAC
$267M
– –
-95,000
Closed -$270K
STOK icon
74
Stoke Therapeutics
STOK
$1.08B
– –
-1,119,963
Closed -$26.7M
MNTA
75
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-2,531,445
Closed -$84.2M
1 2
3